BIVI Stock Forecast 2025 to 2030: Opportunities, Risks, and Key Projections
BioVie Inc. (NASDAQ: BIVI) has garnered significant attention in the biotech sector, known for its focus on neurodegenerative and liver diseases. With its stock currently trading at $2.76 (as of December 2024) and a 52-week high of $33, investors are keen to understand its future trajectory. In this article, we delve into detailed projections for…